According to the MHRA/EMC Summary of Product Characteristics, these include: Very common (may affect more than 1 in 10 people): Nausea Diarrhoea Common (may affect up to 1 in 10 people): Vomiting Abdominal pain Constipation Dyspepsia (indigestion) Decreased appetite These symptoms typically diminish over time as the body adjusts to the medication
GLP-1 is a naturally occurring hormone that regulates appetite, glucose, and fat metabolism
BPC-157 is not a drug, not a dietary supplement, not a cosmetic, and not approved by the FDA, EMA, or any other regulatory authority for use in humans or animals
Reduced Glucagon Release: Semaglutide lowers glucagon levels, which helps prevent unnecessary glucose production by the liver, further aiding in blood sugar control
Telehealth Weight Loss California: GLP-1 Options Telehealth weight loss in California means you can get a prescription for semaglutide or tirzepatide without an in-person doctor visit, with medication shipped directly to your home